Browsing Over 32 Presentations

Sort By
The disappointing results of initial CDKI and their role in other disease (ID 7) Educational session

Q&A (ID 26)

Lecture Time
12:25 - 12:40
Session Name
The disappointing results of initial CDKI and their role in other disease (ID 7)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
24.03.2018
Time
11:10 - 12:40
The disappointing results of initial CDKI and their role in other disease (ID 7) Educational session

CDKi in non-malignant diseases (ID 27)

Lecture Time
12:00 - 12:25
Speakers
  • Laurent Meijer (Roscoff, FR)
Session Name
The disappointing results of initial CDKI and their role in other disease (ID 7)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
24.03.2018
Time
11:10 - 12:40
CDK4 and CDK6 inhibitors in breast cancer (ID 8) Educational session

Palbociclib (ID 28)

Lecture Time
13:30 - 13:50
Speakers
  • Javier Cortes (Madrid, ES)
Session Name
CDK4 and CDK6 inhibitors in breast cancer (ID 8)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
24.03.2018
Time
13:30 - 15:00
CDK4 and CDK6 inhibitors in breast cancer (ID 8) Educational session

Ribociclib (ID 29)

Lecture Time
13:50 - 14:10
Speakers
  • Fabrice AndrĂ© (Villejuif, FR)
Session Name
CDK4 and CDK6 inhibitors in breast cancer (ID 8)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
24.03.2018
Time
13:30 - 15:00
CDK4 and CDK6 inhibitors in breast cancer (ID 8) Educational session

Abemaciclib (ID 30)

Lecture Time
14:10 - 14:30
Speakers
  • Antonio Llombart-Cussac (Valencia, ES)
Session Name
CDK4 and CDK6 inhibitors in breast cancer (ID 8)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
24.03.2018
Time
13:30 - 15:00
CDK4 and CDK6 inhibitors in breast cancer (ID 8) Educational session

Are all CDK 4-6 created equal? (ID 31)

Lecture Time
14:30 - 14:50
Speakers
  • Giuseppe Curigliano (Milan, IT)
Session Name
CDK4 and CDK6 inhibitors in breast cancer (ID 8)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
24.03.2018
Time
13:30 - 15:00
CDK4 and CDK6 inhibitors in breast cancer (ID 8) Educational session

Q&A (ID 32)

Lecture Time
14:50 - 15:00
Session Name
CDK4 and CDK6 inhibitors in breast cancer (ID 8)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
24.03.2018
Time
13:30 - 15:00
Role of CDK 4-6 inhibitors across solid tumors (ID 9) Panel Discussion

Panel Discussion (ID 35)

Lecture Time
15:20 - 16:05
Speakers
  • Alberto Bardelli (Candiolo, IT)
  • Josep Tabernero (Barcelona, ES)
Session Name
Role of CDK 4-6 inhibitors across solid tumors (ID 9)
Location
Auditorium, Vall d'Hebron, Barcelona, Spain
Date
24.03.2018
Time
15:20 - 16:05